Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine-Reference-Cited by-同舟云学术

Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine

Published:2013-11 Issue: Volume:556 Page:37-41
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Yamamori Hidenaga,Hashimoto Ryota,Ishima Tamaki,Kishi Fukuko,Yasuda Yuka,Ohi Kazutaka,Fujimoto Michiko,Umeda-Yano Satomi,Ito Akira,Hashimoto Kenji,Takeda Masatoshi

Funder

Japanese Ministry of Health, Labor and Welfare

Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Japan Foundation for Neuroscience and Mental Health

Publisher

Elsevier BV

Subject

General Neuroscience

Reference23 articles.

1. Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia;Chang;Psychiatry Res.,2011

2. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections;Domenici;PLoS ONE,2010

3. Requirement for BDNF in activity-dependent survival of cortical neurons;Ghosh;Science,1994